WikiRNG
Rolled Version rolled

Xeligekimab

Monoclonal antibody

Xeligekimab (development code GR1501; trade name Jinlixi) is a monoclonal antibody that neutralizes interleukin-17A; it is being developed for plaque psoriasis, axial spondyloarthritis, and lupus nephritis.

SingularityTop 0.092%
2,335,246SP

Badges21 earned

  1. MedicineFabled+2,248,728 SP
    A combination drug, a vaccine, or an experimental drug.
  1. GeneObscure+50,772 SP
    A gene or protein.
  2. OrphanObscure+13,749 SP
    Tagged as an orphan (few links point here).
  1. ZebraNotable+6,935 SP
    The title's letters alternate vowel and consonant (7+ letters).
  2. PubMedNotable+3,084 SP
    Links to PubMed.
  3. UnlinkedNotable+2,526 SP
    No article links here.
  4. PaywalledNotable+2,199 SP
    Cites a source behind a paywall.
  5. Free to ReadNotable+1,723 SP
    Cites a source that is free to read.
  6. WikimonthNotable+1,278 SP
    Created in this month (UTC), any year. ยท Created 2023-11-04
Basic12
rolled by SEEK